Suministros - 452792-2020

25/09/2020    S187

United Kingdom-Birmingham: Medical equipments, pharmaceuticals and personal care products

2020/S 187-452792

Contract notice

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (‘UHCW’)
Postal address: 19 George Road, Edgbaston
Town: Birmingham
NUTS code: UK UNITED KINGDOM
Postal code: B15 1NU
Country: United Kingdom
E-mail: Kirandeep.Pharhani@HTEPG.com
Telephone: +44 08458875000
Internet address(es):
Main address: https://healthtrusteurope.bravosolution.co.uk
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://healthtrusteurope.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://healthtrusteurope.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Endometrial Ablation Devices and Uterine Tissue Removal Systems

Reference number: SF049904
II.1.2)Main CPV code
33000000 Medical equipments, pharmaceuticals and personal care products
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Framework agreement for the supply of endometrial ablation devices and uterine tissue removal systems.

The resulting framework agreement will be in two lots as:

Lot 1: Endometrial Ablation Devices and Associated Products;

Lot 2: Uterine Tissue Removal Systems and Associated Products.

HTE proposes to enter into a framework agreement for a maximum period of 4 years with the successful tenderers, being an initial 2 years period and the option to extend by two periods of 12 months each after the initial period.

II.1.5)Estimated total value
Value excluding VAT: 9 000 000.00 GBP
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 2
II.2)Description
II.2.1)Title:

Endometrial Ablation and Associated Products

Lot No: 1
II.2.2)Additional CPV code(s)
33162000 Operating theatre devices and instruments
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

HealthTrust Europe is seeking to establish a framework agreement for the supply of endometrial ablation devices and associated products including but not limited to; thermal balloon, radiofrequency, microwave devices.

It is envisaged this tender will consist of two lots with an award of up to four suppliers per lot who can offer a breadth of goods.

This contract will be for two years with an option to extend for a further two periods of 12 months each.

Terms and conditions/activity based income (ABI)

The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE.

Submission of expressions of interest and procurement information

This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk

Log into the portal with username/password. Click the SQs/ITTs open to all suppliers link.

These are the SQs/ITTs open to any registered supplier. Click on the relevant SQ/ITT to access the content.

Click the express interest button at the top of the page.

This will move the SQ/ITT into your My SQs/My ITTs page.

You can access any attachments by clicking Buyer Attachments in the SQ/ITT details box.

Follow the on screen instructions to complete the SQ/ITT.

Submit your reply using the submit response button at the top of the page.

If you require any further advice, contact the Bravo eTendering Help Desk at help@bravosolution.co.uk. Sid4Gov

HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk

Please note that sid4gov does not pre-populate any fields of HTE's Bravo portal. Candidates must complete the qualification and technical envelopes in Bravo in full.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
Value excluding VAT: 4 500 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The framework agreement shall be for the period of 2 years with the option to extend for 2 periods of 12 months, each, at the discretion of HealthTrust Europe.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: yes
Description of options:

Option to extend for two periods of 12 months each at the discretion of HealthTrust Europe.

II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Uterine Tissue Removal Systems and Associated Products

Lot No: 2
II.2.2)Additional CPV code(s)
33162000 Operating theatre devices and instruments
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

HealthTrust Europe is seeking to establish a framework agreement for the supply of Uterine tissue removal systems and associated products. It is envisaged this tender will consist of two lots with an award of up to four suppliers per lot who can offer a breadth of goods.

This contract will be for two years with an option to extend for a further two periods of 12 months each.

Terms and conditions/activity based income (ABI)

The terms and conditions of this framework agreement and any resulting call-off contract is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this framework agreement, the management and administration by HTE of the overall contract structure and associated documentation,as well as the requirement to submit regular management information to HTE.

Submission of expressions of interest and procurement information

This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk

Log into the portal with username/password. Click the SQs/ITTs Open to All Suppliers link.

These are the SQs/ITTs open to any registered supplier. Click on the relevant SQ/ITT to access the content.

Click the Express Interest button at the top of the page.

This will move the SQ/ITT into your My SQs/My ITTs page.

You can access any attachments by clicking Buyer Attachments in the SQ/ITT Details box.

Follow the on screen instructions to complete the SQ/ITT.

Submit your reply using the Submit Response button at the top of the page.

If you require any further advice, contact the Bravo eTendering Help Desk at help@bravosolution.co.uk. Sid4Gov

HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at sid4gov@gps.gsi.gov.uk

Please note that sid4gov does not prepopulate any fields of HTE's Bravo portal. Candidates must complete the qualification and technical envelopes in Bravo in full.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
Value excluding VAT: 4 500 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The framework agreement shall be for the period of 2 years with the option to extend for two periods of 12 months each, at the discretion of HealthTrust Europe.

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: yes
Description of options:

Option to extend for two periods of 12 months each at the discretion of HealthTrust Europe.

II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations. Details are provided in the eligibility envelope.

III.1.2)Economic and financial standing
List and brief description of selection criteria:

HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations. Details are provided in the eligibility envelope.

Minimum level(s) of standards possibly required:

HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations. Details are provided in the eligibility envelope.

III.1.3)Technical and professional ability
List and brief description of selection criteria:

HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations. Details are provided in the eligibility envelope.

Minimum level(s) of standards possibly required:

HTE may request such information as may be requested pursuant to Regulation 58 of the Public Contracts Regulations. Details are provided in the eligibility envelope.

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
Envisaged maximum number of participants to the framework agreement: 8
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 22/10/2020
Local time: 17:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English
IV.2.7)Conditions for opening of tenders
Date: 26/10/2020
Local time: 08:00

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.3)Additional information:

The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation 2 of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users:

1) all National Health Service (NHS) bodies in England, including but not limited to:

(i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx),

(ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx),

(iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx),

(iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx),

(v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx),

(vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx),

(vii) special health authorities (http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx),

(viii) NHS England, and

(ix) clinical senates and strategic clinical networks;

2) all NHS bodies in Wales, including but not limited to all:

(i) health boards,

(ii) NHS trusts,

(iii) the national delivery group,

(iv) community health councils, and

(v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure);

3) all NHS bodies in Northern Ireland (known as Health and Social Care), including but not limited to:

(i) health and social care trusts (as listed at: http://online.hscni.net/?s=trusts),

(ii) health agencies (as listed at: http://online.hscni.net/?s=health+agencies),

(iii) hospitals (as listed at: http://online.hscni.net/?s=hospitals), and

(iv) the Health and Social Care Board.

4) social enterprises undertaking some or all of the previous service provider functions of contracting authorities in relation to health and/or social care services (including charitable incorporated organisations, cooperatives, industrial and provident societies and community interest companies listed on the Companies House WebCheck service);

5) ministerial departments and non-ministerial departments of central government, nondepartmental agencies and other public bodies, and public corporations (as listed at: https://www.gov.uk/government/organisations);

6) devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at:

http://www.assembly.wales/en/abthome/role-of-assembly-how-it-works/Pages/governanceofwales.aspx);

7) all local authorities (as listed at: http://local.direct.gov.uk/LDGRedirect/Start.do?mode=1);

8) the Ministry of Defence (as detailed at: https://www.gov.uk/government/organisations/ministry-of-defence).

This list includes each organisation's successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes. This agreement will be open to any bodies or organisations operating in the UK of a health and/or social care nature or which have a similar procurement need and/or any UK based central government authority listed at Annex I of Directive 2014/24/EU, in respect of any goods or services to any of the above listed organisations.

VI.4)Procedures for review
VI.4.1)Review body
Official name: Legal Department, HealthTrust Europe LLP
Postal address: 19 George Road
Town: Birmingham
Postal code: B15 1NU
Country: United Kingdom
E-mail: legaltasks@htepg.com
Telephone: +44 8458875000
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

HTE will incorporate a standstill period at the point information on the award of the framework agreement is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the agreement is entered into.

VI.5)Date of dispatch of this notice:
22/09/2020